Having cleared the hurdle as a treatment for diabetes, the FDA then approved semaglutide, marketed as Wegovy, for obesity in 2021, and then in Europe the following year
Your provider can reference clinical guidelines (ADA, AMA) supporting tirzepatide use, comorbidities justifying therapy, and any biomarker data strengthening the case
2023;133:e169131
These drugs demonstrate promising efficacy in weight management, appetite reduction, and energy expenditure enhancement
If you have commercial insurance, it's worth checking your plan's formulary for Wegovy or Zepbound coverage before enrolling in a cash-pay compounded program
As a proven sales leader with Align, he supported several successful teams and innovative projects, including Invisalign Pro, Patient Financing, ADAPT Consulting, Ortho Marketing Board, and Retainer and Doctor Subscription program